Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ANGO
ANGIODYNAMICS, INC.
NASDAQ
$15.75
▼ DOWN 0.44% (-0.07)

KEY STATISTICS

Market Cap$650.99 M
52w High$16.29
52w Low$9.39
Dividend Yield—
Frequency—
P/E-40.38
Volume150.06K
Shares Out.41.33M

COMPANY

LEADERSHIP

James C. Clemmer
CHIEF EXECUTIVE
James C. Clemmer

COMPENSATION 2026

Salary$803,027
Stock Awards$2,628,871
Incentive Plan Pay$1,215,608
All Other Comp.$38,572
Total$5,494,285

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 1, 2004
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
632

PRICE TARGET

Target High$20.00
Target Low$19.00
Target Median$19.50
Target Consensus$19.50

UPCOMING EARNINGS

DateOct 1, 2026
DayThursday
Rev. Est.$80.51M
OCT
1
THU

PRICE

$15.75 ▼ DOWN 0.44% (−$0.07)
$15.60$15.75$15.909:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM15.75

About AngioDynamics, Inc.

https://www.angiodynamics.com ↗

AngioDynamics designs and sells medical devices for vascular, oncology, and surgical treatments worldwide, including ablation systems, catheters, and access products for healthcare professionals.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT ANGIODYNAMICS, INC. IS KNOWN FOR

AlphaVac F18 85 System
AlphaVac F18 85 System

An FDA-cleared intravascular thrombectomy device for non-surgical removal of pulmonary blood clots, emphasizing its role in AngioDynamics' cardiovascular market focus.

COMPETITORS

COMPETITOR
BSX COMPARE
MDT COMPARE
MMSI COMPARE
PEN COMPARE
TFX COMPARE

Revenue by Products

IconPRODUCTQ2-2025Q3-2025Q2-2026Q3-2026
Med Device$41.29M $40.66M ▼$43.78M ▲$41.14M ▼
Med Tech$31.55M $31.34M ▼$35.65M ▲$37.28M ▲

Revenue by Geography

MapREGIONQ4-2025Q2-2026Q3-2026Q4-2026
UNITED STATES$67.48M $67.59M ▲$67.28M ▼$140.05M ▲
NonUS— $11.84M $11.14M ▼$22.27M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
88
LISTED HERE
18
RANKED BY POSITION SIZE
VTI
0.00% · 1.2M
IWM
0.02% · 958.2K
SCHA
0.01% · 199.9K
DFMC
0.03% · 143.6K
FESM
0.03% · 111.2K
AVSC
0.05% · 89.9K
R2SC.L
0.02% · 74.9K
PRFZ
0.04% · 68.2K
GSSC
0.09% · 60.4K
XRS2.F
0.02% · 34.3K
RSSL
0.02% · 17.7K
RFLR
0.06% · 3.6K
TYNE
1.68% · 1.7K
URTY
0.01% · 1.5K
DM
DMRS
0.07% · 1.1K
FESC
0.15% · 223
FVI
0.02% · 201
RESM
0.03% · 105

INSTITUTIONAL OWNERSHIP

SHARES OWNED
77.24%
HOLDERS
259
TOP 12 OF 259 · RANKED BY POSITION SIZE
Blackrock Inc.
4.6M sh · $27.86M
Blackrock, Inc.
3.9M sh · $49.57M
Divisadero Street Capital Management, LP
3.7M sh · $41.08M
Point72 Asset Management, L.P.
3.2M sh · $36.18M
Systematic Financial Management LP
2.6M sh · $34.35M
Blackrock Fund Advisors
2.5M sh · $42.4M
Vanguard Group Inc
2.4M sh · $31.29M
Armistice Capital, LLC
2.2M sh · $28.6M
Royce & Associates LP
2.0M sh · $25.63M
Millennium Management LLC
1.8M sh · $20.03M
KK
Kotler Kevin
1.7M sh · $22M
State Street Corp
1.3M sh · $15.17M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book3
Overall Score2

TRADES BY CONGRESS

HOUSE TRADES
Debbie Wasserman Schultz
Debbie Wasserman Schultz
Sale
2025-10-20

INSIDER TRADES

★
OFFICER: SVP QUALITY AND REGULATORY
Nighan Warren JR
Sale · 23.4K shares
2026-07-30
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Clemmer James C
Sale · 184.4K shares
2026-07-22
★
OFFICER: SVP/GM, VASCULAR ACCESS
Campbell Chad Thomas
Sale · 22.8K shares
2026-07-22
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Clemmer James C
Purchase · 52.4K shares
2026-07-22

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
2 GRADES IN THE LAST 12 MONTHS
Canaccord Genuity BUY HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
SNDA$39.56COMPARE
OMER$19.27COMPARE
CGEM$21.68COMPARE
VREX$18.51COMPARE
OCGN$1.39COMPARE
NMRA$1.63COMPARE
SY$2.29COMPARE
FULC$3.83COMPARE